Bainco International Investors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$10.8M Buy
174,278
+100,263
+135% +$6.17M 1.24% 30
2020
Q3
$4.46M Buy
74,015
+2,574
+4% +$155K 0.57% 57
2020
Q2
$4.2M Buy
71,441
+71,110
+21,483% +$4.25M 0.6% 58
2020
Q1
$18K Buy
+331
New +$20.2K ﹤0.01% 154
2018
Q4
Sell
-112,782
Closed -$7M 97
2018
Q3
$7M Buy
112,782
+1,744
+2% +$103K 0.96% 45
2018
Q2
$6.14M Sell
111,038
-535
-0.5% -$28.9K 0.89% 46
2018
Q1
$7.06M Sell
111,573
-1,954
-2% -$126K 1.05% 38
2017
Q4
$7.25M Buy
113,527
+1,977
+2% +$124K 1.06% 37
2017
Q3
$7.11M Buy
111,550
+4,840
+5% +$283K 0.85% 40
2017
Q2
$5.95M Sell
106,710
-6,405
-6% -$349K 0.89% 42
2017
Q1
$6.15M Sell
113,115
-10,420
-8% -$572K 0.87% 41
2016
Q4
$7.22M Buy
+123,535
New +$6.75M 1.23% 36

Other funds holding BMY

Bainco International Investors's BMY Position: Q4 2020 in Review

Bainco International Investors increased its Bristol-Myers Squibb (BMY) stake by 135% in Q4 2020, buying an estimated $6.17M and bringing the position to 174,278 shares worth $10.8M. The position accounts for 1.24% of the portfolio, ranked #30.

Bainco International Investors first reported a position in BMY in Q4 2016 and has held it in 12 quarters since. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Bainco International Investors held 174,278 shares of Bristol-Myers Squibb worth $10.8M as of Q4 2020.
  • Bainco International Investors bought 100,263 Bristol-Myers Squibb shares in Q4 2020, an estimated $6.17M.
  • Bristol-Myers Squibb made up 1.24% of Bainco International Investors's portfolio in Q4 2020, its #30 holding.
  • Bainco International Investors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 12 quarters since.
  • 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.